Celltrion Secures South Korean Phase 1 Approval for Tremfya Biosimilar CT-P68
Celltrion announced on July 15 that it has received approval from South Korea’s Ministry of Food and Drug Safety for an investigational new drug...
Search results for "United States"
The Next Level of Joint Care: Why Robot-Assisted Hip Surgery Demands a Higher Class of Surgical Expertise
A man in his 60s, referred to as Mr. A, recently visited a clinic to address chronic knee pain. He felt an immediate sense of reassurance when his...
Daewoong Pharmaceutical’s Nabota Hits 1 Trillion Won in Cumulative Sales 12 Years Post-Launch
Daewoong Pharmaceutical announced on the 13th that its flagship botulinum toxin product, Nabota, surpassed 1 trillion...
Don’t Toss Those Banana Peels: Three Smart Ways to Rid Your Kitchen of Fruit Flies
Fruit flies become a notorious seasonal nuisance in the summer, swarming around kitchens and leaving living spaces...
Seconds Count: Three Essential Strategies to Prevent Child Drowning During Water Play
Data from the U.S. Centers for Disease Control and Prevention reveals that between 4,000 and 5,000 people die by...
Get Second and Third Opinions Before Spine Surgery, Urges Renowned Scoliosis Surgeon Kim Yong-jung
Dr. Kim Yong-jung, Director of the Spinal Deformity Center at Seoul Bumin Hospital, has performed approximately 2,400...
Venezuela’s Earthquake Disaster: Paralyzed State and Collapsed Healthcare Magnify the Tragedy
Venezuela is facing a deepening humanitarian crisis after a powerful earthquake struck at approximately 6 p. m.
AI-generated faces look more trustworthy than real people. Here’s why.
A short social media video showing a woman seated in the stands at a professional baseball stadium drew attention after...
Elevated Phthalate Levels in Newborn Urine Linked to Dramatic Rise in Childhood Atopic Dermatitis
Another study has added to the growing body of evidence that endocrine-disrupting chemicals can cause direct,...
MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem
South Korean biotechnology company MediPost has entered full-scale Phase 3 clinical testing in the United States for...